Health AI Central
Peer-Reviewed Publication
Cytotherapy2026;28(11):102899.November 1, 2026Journal Article

From classroom to cleanroom: building a skilled cell and gene therapy workforce.

Ali Shokoohmand1, Eddie H P Tan2, Arwa Z Al-Riyami3, Anna Koptina4, Colleen Richards5, Mariana Morato-Marques6, Piriya Yoganathan7, Nouf Al-Rasheed8, Gemma Moir-Meyer9, Nikita M Patel10, Alicia Didsbury11, Jennifer L Quizi7, Michael J Medlyn12, Timothy D Wiltshire12, Dominic Fernandez13, Laura Garcia-Gerique14, Janet Macpherson15, Rachel A Burga16, Matthew Hewitt17, Patrick J Hanley18, Zlatibor Velickovic19
1School of Chemical Engineering, Faculty of Engineering, Architecture and Information Technology, The University of Queensland, Queensland, Australia. Electronic address: a.shokoohmand@gmail.com.
2Centre of Regulatory Excellence, Duke-NUS Medical School, National University of Singapore, Singapore.
3Department of Hematology, Sultan Qaboos University Hospital, University Medical City, Seeb, Oman; College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman.
4Exellerium AB, Stockholm, Sweden.
5Patheon Pharmaceuticals Services Inc, Waltham, Massachusetts, USA.
6Hospital Israelita Albert Einstein, São Paulo, Brazil.
7Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
8Pathology and Laboratory Medicine Division, Hematopathology and Transfusion Medicine Department, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
9Department of Medicine, Christchurch Heart Institute, University of Otago, Christchurch, New Zealand.
10INmune Bio International, Royal Free Hospital, London, UK.
11Faculty of Science, Biological Sciences, University of Auckland, Auckland, New Zealand.
12Department of Lab Medicine and Pathology, Division of Transfusion Medicine, Mayo Clinic, Rochester, Minnesota, USA.
13Epworth Centre for Immunotherapies and Snowdome Laboratories, Epworth Healthcare, Melbourne, Victoria, Australia.
14Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.
15NSW Health Pathology, Cell Therapy Program, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
16Obsidian Therapeutics, Cambridge, Massachusetts, USA.
17Charles River Laboratories, Wilmington, Massachusetts, USA; Technical Officer CGT & Biologics, Hanover, Maryland, USA.
18Center for Cancer and Immunology Research, Children's National Hospital and George Washington University, Washington, DC, USA.
19Cell & Tissue Therapies WA, Royal Perth Hospital, Perth, Western Australia, Australia; University of Western Australia, Perth, Western Australia, Australia.
PubMed DOI

Abstract

The demand for the CGT workforce exceeds the capacity of current training programs to produce professionals ready for Good Manufacturing Practice (GMP) operations and associated quality and regulatory requirements. Most academic programs build strong scientific foundations but do not consistently prepare learners for process development and disciplined practice within regulated quality systems, re…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.